Key result
Medical therapy with verapamil or propranolol over 33 months in patients with HOCM did not halt disease progression, as myocardial cell diameter increased from 16.2 to 20.3 mu.
Why the study?
Does medical therapy (verapamil or propranolol) prevent the morphological progression of myocardial hypertrophy in patients with hypertrophic cardiomyopathy?
Observational (n=38)
Does medical therapy (verapamil or propranolol) prevent the morphological progression of myocardial hypertrophy in patients with hypertrophic cardiomyopathy?
Left ventricular biopsies from 38 patients with hypertrophic cardiomyopathy (HOCM 28, HNCM 10) were investigated to evaluate possible correlations between morphological and clinical parameters. No correlation was found between the degree of myocardial hypertrophy (muscle cell diameter), nuclear size of the myocytes, fibrous tissue content and various clinical data such as pressure gradient, left ventricular end-diastolic pressure, Sokolow index and heart volume. In 11 patients with HOCM, a second biopsy was performed after medical therapy (verapamil, n = 9; propranolol, n = 2) over 33 +/- 12 months. Increasing myocardial hypertrophy (cell diameter 16.2 +/- 4.4 mu vs. 20.3 +/- 4.2 mu) was observed in all 11 patients. The interstitial fibrous tissue content increased from 5.7 +/- 6.3 to 12.7 +/- 6.8%. The volume fraction of myofibrils decreased (48.8 +/- 2.7 vs. 43.6 +/- 5.3%). The morphological changes were observed regardless of the clinical outcome which was improved in four, unchanged in five and worsened in two cases. The underlying hypertrophic process in HCM seems to be slowly progressive in most patients and cannot be influenced by medical treatment.
No takes yet. Share an insight, caveat, or question.
Kunkel et al. (1988) conducted an observational in Hypertrophic cardiomyopathy (n=38). Medical therapy (verapamil or propranolol) vs. Baseline (pre-therapy) was evaluated on Myocardial cell diameter (mu). Medical therapy with verapamil or propranolol over 33 months in patients with HOCM did not halt disease progression, as myocardial cell diameter increased from 16.2 to 20.3 mu.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: